Prediction and reversion of post-transplant relapse in patients with chronic myeloid leukemia using mixed chimerism and residual disease detection and adoptive immunotherapy
To access this article, please choose from the options below
PII: S0145-2126(99)00185-X
© 2000 Elsevier Science Ltd. All rights reserved.
